This article was originally published in The Rose Sheet
Executive SummaryFine fragrance revenue grew by double digits for the first nine months due to significant new launches and strong performance of specialty retail and direct-selling channels, Givaudan reports Oct. 9. Consumer Products business experienced high single-digit growth in local currencies with strong win rates achieved in hair care. Fragrance division sales fell 1.7% to $643.9 mil. (CH1=$.76). In local currencies, division sales were up 5.2%. Givaudan's net sales for the period grew 1.1% in Swiss Francs on a reported basis to $1.58 bil. Revenue was down 4.6% on a pro forma basis, assuming the acquisition of Nestle's flavor activities had taken place Jan. 1...
You may also be interested in...
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.